Neoadjuvant pembrolizumab may result in long-term outcome improvement in biomarker-unselected patients with Muscle-Invasive Bladder Cancer (MIBC): Updated results from PURE-01
EUROPEAN UROLOGY（2022）
关键词
neoadjuvant pembrolizumab,bladder,mibc,long-term,biomarker-unselected,muscle-invasive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要